LGALS13 antibody (AA 30-139)
Quick Overview for LGALS13 antibody (AA 30-139) (ABIN7268198)
Target
See all LGALS13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 30-139
-
Purpose
- LGALS13 Rabbit pAb
-
Sequence
- FINDPQLQVD FYTDMDEDSD IAFRFRVHFG NHVVMNRREF GIWMLEETTD YVPFEDGKQF ELCIYVHYNE YEIKVNGIRI YGFVHRIPPS FVKMVQVSRD ISLTSVCVCN
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 30-139 of human LGALS13 (NP_037400.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))
-
Alternative Name
- LGALS13
-
Background
- Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family. [provided by RefSeq, Jul 2008],GAL13,PLAC8,PP13,LGALS13,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Blood,Serum Proteins,LGALS13
-
Molecular Weight
- 16kDa
-
Gene ID
- 29124
-
UniProt
- Q9UHV8
Target
-